Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
Millendo Therapeutics, Inc. - Common Stock (MLND)
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am
Check Earnings Report
Company Research
Source: Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases with significant unmet needs, today announced that Geoff Nichol, M.B., Ch.B., M.B.A., has been appointed to the Board of Directors. Dr. Nichol currently serves as Chief Medical Officer at BioMarin where he oversees an active portfolio of clinical development programs and has led multiple programs through late-stage clinical studies and regulatory approval.“We welcome the deep expertise and insights from Dr. Nichol,” said Julia C. Owens, Ph.D., President and Chief Executive Officer at Millendo Therapeutics. “His experience across the full spectrum of drug development, particularly in rare diseases and late-stage clinical development, as well as his strong knowledge of the regulatory approval process complements our current board. His perspective will have significant impact as we plan
Show less
Read more
Impact Snapshot
Event Time:
MLND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLND alerts
High impacting Millendo Therapeutics, Inc. - Common Stock news events
Weekly update
A roundup of the hottest topics